Skip to main content
Top
Published in: Supportive Care in Cancer 2/2021

01-02-2021 | Esophageal Cancer | Original Article

Falls: descriptive rates and circumstances in age-unspecified patients with locally advanced esophageal cancer

Authors: Daniel S. Childs, Harry H. Yoon, Rachel A. Eiring, Zhaohui Jin, Jacob A. Jochum, Henry C. Pitot, Aminah Jatoi

Published in: Supportive Care in Cancer | Issue 2/2021

Login to get access

Abstract

Purpose

Falls can occur in older cancer patients, but few studies have examined falls in an age-unspecified group of patients with locally advanced esophageal cancer. Because these patients are often administered neuropathy-inducing agents, are weak, and can develop orthostatic symptoms, examining falls appears relevant.

Methods

Electronic medical records were used to examine falls and their circumstances in locally advanced esophageal cancer patients treated with chemotherapy and radiation and often surgery.

Results

Among 300 patients, 62 (21%) suffered a fall, yielding 6 falls per 100 patient years. The median age at first fall was 64 years (range 31 to 83). The median time from cancer diagnosis to first fall was 11 months (range 0 to 107). Forty-two patients (68%) who fell had active cancer; 20 (32%) were cancer-free. Fall-related injuries occurred in 42 patients and included fractures, hematomas, and other musculoskeletal events. Eighteen patients (29%) fell repeatedly. Neuropathy, general weakness, and orthostatic symptoms were associated with falls (“He does state his neuropathy is more bothersome…. He did have a fall last week….” “He has been increasingly weak to the point where he fell down last week….” “Upon rising… [he] felt like somebody had put a sheet over his eyes, felt very lightheaded, and fell to the floor….”). At times, falls occurred under commonplace circumstances, such as slipping on ice or tripping on an underfoot pet.

Conclusion

Regardless of patient age, clinicians should remain vigilant for fall risk in adult patients with locally advanced esophageal cancer.
Literature
1.
go back to reference Florence CS, Bergen G, Atherly A, Burns E, Stevens J, Drake C (2018) Medical costs of fatal and nonfatal falls in older adults. J Am Geriatr Soc 66(4):693–698CrossRef Florence CS, Bergen G, Atherly A, Burns E, Stevens J, Drake C (2018) Medical costs of fatal and nonfatal falls in older adults. J Am Geriatr Soc 66(4):693–698CrossRef
2.
go back to reference Wildes TM et al (2018) Factors associated with falls in older adults with cancer: a validated model from the Cancer and Aging Research Group. Support Care Cancer 26(10):3563–3570CrossRef Wildes TM et al (2018) Factors associated with falls in older adults with cancer: a validated model from the Cancer and Aging Research Group. Support Care Cancer 26(10):3563–3570CrossRef
3.
go back to reference Noone AM, H.N., Krapcho M, Miller D, Brest A, Yu M. SEER cancer statistics review, 1975–2015. 2017 [cited 2020 January 14, 2020] Noone AM, H.N., Krapcho M, Miller D, Brest A, Yu M. SEER cancer statistics review, 1975–2015. 2017 [cited 2020 January 14, 2020]
4.
go back to reference Komatsu H, Yagasaki K, Komatsu Y, Yamauchi H, Yamauchi T, Shimokawa T, Doorenbos AZ (2019) Falls and functional impairments in breast cancer patients with chemotherapy-induced peripheral neuropathy. Asia Pac J Oncol Nurs 6(3):253–260CrossRef Komatsu H, Yagasaki K, Komatsu Y, Yamauchi H, Yamauchi T, Shimokawa T, Doorenbos AZ (2019) Falls and functional impairments in breast cancer patients with chemotherapy-induced peripheral neuropathy. Asia Pac J Oncol Nurs 6(3):253–260CrossRef
5.
go back to reference McCrary JM, Goldstein D, Trinh T, Timmins HC, Li T, Menant J, Friedlander M, Lewis CR, Hertzberg M, O’Neill S, King T, Bosco A, Harrison M, Park SB (2019) Balance deficits and functional disability in cancer survivors exposed to neurotoxic cancer treatments. J Natl Compr Cancer Netw 17(8):949–955CrossRef McCrary JM, Goldstein D, Trinh T, Timmins HC, Li T, Menant J, Friedlander M, Lewis CR, Hertzberg M, O’Neill S, King T, Bosco A, Harrison M, Park SB (2019) Balance deficits and functional disability in cancer survivors exposed to neurotoxic cancer treatments. J Natl Compr Cancer Netw 17(8):949–955CrossRef
6.
go back to reference Najafpour Z, Godarzi Z, Arab M, Yaseri M (2019) Risk factors for falls in hospital in-patients: a prospective nested case control study. Int J Health Policy Manag 8(5):300–306CrossRef Najafpour Z, Godarzi Z, Arab M, Yaseri M (2019) Risk factors for falls in hospital in-patients: a prospective nested case control study. Int J Health Policy Manag 8(5):300–306CrossRef
7.
go back to reference Stone CA, Lawlor PG, Savva GM, Bennett K, Kenny RA (2012) Prospective study of falls and risk factors for falls in adults with advanced cancer. J Clin Oncol 30(17):2128–2133CrossRef Stone CA, Lawlor PG, Savva GM, Bennett K, Kenny RA (2012) Prospective study of falls and risk factors for falls in adults with advanced cancer. J Clin Oncol 30(17):2128–2133CrossRef
8.
go back to reference Tofthagen C, Overcash J, Kip K (2012) Falls in persons with chemotherapy-induced peripheral neuropathy. Support Care Cancer 20(3):583–589CrossRef Tofthagen C, Overcash J, Kip K (2012) Falls in persons with chemotherapy-induced peripheral neuropathy. Support Care Cancer 20(3):583–589CrossRef
9.
go back to reference Wildes TM, Dua P, Fowler SA, Miller JP, Carpenter CR, Avidan MS, Stark S (2015) Systematic review of falls in older adults with cancer. J Geriatr Oncol 6(1):70–83CrossRef Wildes TM, Dua P, Fowler SA, Miller JP, Carpenter CR, Avidan MS, Stark S (2015) Systematic review of falls in older adults with cancer. J Geriatr Oncol 6(1):70–83CrossRef
10.
go back to reference Sattar S, Alibhai SMH, Spoelstra SL, Puts MTE (2019) The assessment, management, and reporting of falls, and the impact of falls on cancer treatment in community-dwelling older patients receiving cancer treatment: results from a mixed-methods study. J Geriatr Oncol 10(1):98–104CrossRef Sattar S, Alibhai SMH, Spoelstra SL, Puts MTE (2019) The assessment, management, and reporting of falls, and the impact of falls on cancer treatment in community-dwelling older patients receiving cancer treatment: results from a mixed-methods study. J Geriatr Oncol 10(1):98–104CrossRef
11.
go back to reference Guerard EJ, Deal AM, Williams GR, Jolly TA, Nyrop KA, Muss HB (2015) Falls in older adults with cancer: evaluation by oncology providers. J Oncol Pract 11(6):470–474CrossRef Guerard EJ, Deal AM, Williams GR, Jolly TA, Nyrop KA, Muss HB (2015) Falls in older adults with cancer: evaluation by oncology providers. J Oncol Pract 11(6):470–474CrossRef
12.
go back to reference Sattar S, Alibhai SMH, Spoelstra SL, Fazelzad R, Puts MTE (2016) Falls in older adults with cancer: a systematic review of prevalence, injurious falls, and impact on cancer treatment. Support Care Cancer 24(10):4459–4469CrossRef Sattar S, Alibhai SMH, Spoelstra SL, Fazelzad R, Puts MTE (2016) Falls in older adults with cancer: a systematic review of prevalence, injurious falls, and impact on cancer treatment. Support Care Cancer 24(10):4459–4469CrossRef
13.
go back to reference Haddad YK, Bergen G, Lou F (2018) Reducing fall risk in older adults. Am J Nurs 118:21–22CrossRef Haddad YK, Bergen G, Lou F (2018) Reducing fall risk in older adults. Am J Nurs 118:21–22CrossRef
14.
go back to reference Elliott JA, Doyle SL, Murphy CF, King S, Guinan EM, Beddy P, Ravi N, Reynolds JV (2017) Sarcopenia: prevalence, and impact on operative and oncologic outcomes in the multimodal management of locally advanced esophageal cancer. Ann Surg 266(5):822–830CrossRef Elliott JA, Doyle SL, Murphy CF, King S, Guinan EM, Beddy P, Ravi N, Reynolds JV (2017) Sarcopenia: prevalence, and impact on operative and oncologic outcomes in the multimodal management of locally advanced esophageal cancer. Ann Surg 266(5):822–830CrossRef
15.
go back to reference Jarvinen T et al (2018) Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study. World J Surg Oncol 16(1):27CrossRef Jarvinen T et al (2018) Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study. World J Surg Oncol 16(1):27CrossRef
16.
go back to reference Levolger S, van Vugt JLA, de Bruin RWF, IJzermans JNM (2015) Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies. Br J Surg 102(12):1448–1458CrossRef Levolger S, van Vugt JLA, de Bruin RWF, IJzermans JNM (2015) Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies. Br J Surg 102(12):1448–1458CrossRef
Metadata
Title
Falls: descriptive rates and circumstances in age-unspecified patients with locally advanced esophageal cancer
Authors
Daniel S. Childs
Harry H. Yoon
Rachel A. Eiring
Zhaohui Jin
Jacob A. Jochum
Henry C. Pitot
Aminah Jatoi
Publication date
01-02-2021
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 2/2021
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-020-05511-z

Other articles of this Issue 2/2021

Supportive Care in Cancer 2/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine